Core Viewpoint - Harvard Bioscience, Inc. is actively engaging with investors through participation in two upcoming conferences in March 2025, highlighting its commitment to investor relations and transparency [1][2]. Company Overview - Harvard Bioscience, Inc. is a prominent developer, manufacturer, and seller of technologies and services that facilitate advancements in life sciences, including research, pharmaceutical discovery, bio-production, and preclinical testing [1]. - The company's customer base includes prestigious academic institutions, government laboratories, and leading pharmaceutical and biotechnology firms, indicating a strong market presence [1]. Upcoming Events - The 37th Annual Roth Conference will take place from March 16-18, 2025, where management will conduct one-on-one meetings and participate in a Fireside Chat on March 17 at 10 a.m. PT [2]. - A virtual event, the KeyBanc Capital Markets Healthcare Forum, is scheduled for March 19, 2025, featuring one-on-one meetings and a Fireside Chat with Paul Knight at 3:45 p.m. ET [2].
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025